Labshake search
Citations for R&D Systems :
1 - 50 of 1879 citations for Follicle stimulating hormone FSH Human HEK293 Flag His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2024Quote: ... human recombinant macrophage-colony stimulating factor (M-CSF, R&D Systems), Lysoview-633 (biotium) ...
-
bioRxiv - Cell Biology 2023Quote: ... HEK293-derived human Shh (R&D Systems, 8908-SH) served as a bioactivity control and to quantify Bosc23-expressed ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems, Minneapolis, MN), recombinant human interleukin 4 (IL-4 ...
-
bioRxiv - Microbiology 2024Quote: ... and differentiated into M1 or M2 macrophages by incubation for 7 days in the presence of 100 ng/mL recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) or macrophage-colony stimulating factor (M-CSF) (R&D Systems, Minneapolis, MN, USA), respectively.
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant TGF-β1 (#240-B-002) and human growth hormone Genotropin (Pfizer) procured from R&D Systems.
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 25 ng/ml human macrophages colony-stimulating factor (M-CSF) (R&D Systems) for 4 days to stimulate macrophage differentiation ...
-
bioRxiv - Systems Biology 2019Quote: ... growth hormone (DGH00, R&D Systems, MN), and total IGF-1 (DG100 ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (50 ng/mL) (R&D Systems) and recombinant human interleukin-4 (IL-4 ...
-
bioRxiv - Cancer Biology 2023Quote: ... The ligands used were His-Tagged human CD38 (R&D systems, catalog # 2404-AC ...
-
bioRxiv - Microbiology 2021Quote: ... with 10% FBS (Wisent) and 0.5 ng/ml recombinant human Macrophage Colony Stimulating factor (M-CSF) (R&D Systems) to allow for differentiation of monocytes into macrophages ...
-
bioRxiv - Molecular Biology 2022Quote: ... human recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF, 50 ng/mL R&D Systems, 7954-GM-020/CF), and interleukin-4 (IL-4 ...
-
bioRxiv - Immunology 2020Quote: ... and 10 ng/mL of human macrophage colony stimulating factor (M-CSF, R&D Systems, catalog number 216-MC) for at least 10 days to generate mature macrophages before use in experiments.
-
bioRxiv - Bioengineering 2020Quote: ... anti-Müllerian hormone (AMH) (R&D Systems, Minneapolis, MN), and vascular endothelial growth factor (VEGF ...
-
bioRxiv - Immunology 2021Quote: ... Recombinant human His-tagged CD80 (R&D Systems 9050-B1, Minneapolis, MN, USA) or CD86 (R&D Systems 9090-B2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and recombinant human TIM-4-HIS (R&D Systems, Cat# 9407-TM-050)) ...
-
bioRxiv - Microbiology 2024Quote: ... Monocytes were differentiated into hMDMs for at least 7 days in complete medium containing 10 ng.mL-1 of recombinant human macrophage colony-stimulating factor (rhM-CSF; R&D systems).
-
bioRxiv - Cancer Biology 2019Quote: ... Active CD73 enzyme (Recombinant Human 5’-Nucleotidase/CD73 Protein, CF) and active CD39 (His-Tag Human) were from R&D Systems, Minneapolis ...
-
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV epitopesbioRxiv - Immunology 2020Quote: ... containing 10% fetal bovine serum and 0.5% gentamicin in the presence of 1000 IU/ml of human granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D Systems, Minneapolis, MN) and 1000 IU/ml of interleukin 4 (IL-4 ...
-
bioRxiv - Cancer Biology 2023Quote: ... TF1 cells were cultured in RPMI-1640 with 10% FBS and 1 ng/mL recombinant human granulocyte–macrophage colony-stimulating factor (rhGM-CSF, No. 215-GM, R&D Systems, Minneapolis, MN). 293T cells were cultured in DMEM media containing 10% FBS ...
-
bioRxiv - Microbiology 2019Quote: ... and granulocyte-macrophage colony stimulating factor (R&D Systems, MN). Aliquots of 0.05mL of each dilution were added to 12 wells (first dilution corresponds to 20,000 cells per well ...
-
bioRxiv - Neuroscience 2021Quote: ... Media was then exchanged to DMEM containing 15 ng/mL recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF; R&D Systems # 215-GM-010/CF). PBMC Mϕ were allowed to differentiate for an additional 5 days and were returned to DMEM 10% FBS until stimulation.
-
bioRxiv - Immunology 2022Quote: ... and 100 ng/ml macrophage colony stimulating factor (R&D systems). For replication experiments with full-length viruses ...
-
bioRxiv - Microbiology 2020Quote: ... and 40 ng/ml macrophage colony stimulating factor (R&D systems). Cells were further washed after 3 days and the medium changed to RPMI supplemented with 10% heat-inactivated human serum (Sigma) ...
-
bioRxiv - Microbiology 2019Quote: ... and 40 ng/ml macrophage colony stimulating factor (R&D systems). Cells were further washed after 3 days and the medium changed to RPMI supplemented with 10 % heat-inactivated FBS ...
-
bioRxiv - Cell Biology 2021Quote: ... monocyte colony stimulating factor (M-CSF, 20ng/mL, R&D Systems). EOC2 cultures were maintained in DMEM media supplemented with 10% HI FBS ...
-
bioRxiv - Neuroscience 2022Quote: ... recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems), and recombinant IL-34 (IL-34 ...
-
bioRxiv - Immunology 2019Quote: ... with 800 U/mL granulocytemacrophage colony-stimulating factor (R&D Systems) and 1000 U/mL IL4 (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... cells were treated for 24h with 100ng/ml media of human recombinant GBA (rhGBA-His (R&D Systems)).
-
bioRxiv - Synthetic Biology 2022Quote: ... and 50 μg/ml parathyroid hormone receptor (PTH, R&D systems 5709-PR-50) were separately immobilized on Ni-NTA tips for at least 5 min ...
-
bioRxiv - Cancer Biology 2020Quote: ... with C-terminal 6xHis tag produced in HEK293 cells and human recombinant PD-L1-Fc chimera protein produced in mouse NS0 cells were obtained from R&D Systems, Minneapolis ...
-
bioRxiv - Immunology 2021Quote: GM-CSF (Granulocyte Macrophage Colony Stimulating Factor) (R&D Systems, Minneapolis, USA), M-CSF (Macrophage Colony Stimulating Factor ...
-
bioRxiv - Immunology 2019Quote: ... 50 ng/ml Granulocyte-macrophage colony-stimulating factor (R&D Systems, Minneapolis, MN); 50 ng/ml IL-4 (R&D Systems) ...
-
bioRxiv - Microbiology 2020Quote: ... and 50 ng/ml recombinant granulocyte–macrophage colony-stimulating factor (R&D Systems) for 7 days at 37° C ...
-
bioRxiv - Cell Biology 2021Quote: ... Murine Macrophage colony stimulating factor (M-CSF) was sourced from R&D Systems.
-
bioRxiv - Immunology 2021Quote: ... and 20 ng/mL monocyte colony-stimulating factor (M-CSF, R&D Systems). Cells were maintained at 37 °C with 5% CO2 and the medium was replaced on day 2 and day 4.
-
bioRxiv - Microbiology 2023Quote: ... and 50 ng/mL macrophage colony-stimulating factor (M-CSF, R&D Systems) and incubated at 37°C in 5% CO2 for 7 days.
-
Fine tuning of CpG spatial distribution with DNA origami for improved therapeutic cancer vaccinationbioRxiv - Synthetic Biology 2023Quote: ... 20 ng/mL granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D Systems) and penicillin–streptomycin ...
-
bioRxiv - Cancer Biology 2024Quote: ... and 20 ng/mL monocyte colony-stimulating factor (M-CSF, R&D Systems) at 37°C with 5% CO2 ...
-
bioRxiv - Immunology 2022Quote: ... Anti-human CD28 antibody and recombinant mouse ICAM-1/CD54 His-tag were purchased from R&D Systems (Minneapolis, MN, USA). Hybridoma cell lines for mouse anti-CD3 (145-2C11 ...
-
bioRxiv - Biochemistry 2021Quote: ... and 30 ng/ml macrophage colony-stimulating factor (M-CSF; R&D Systems, USA) at 37°C and 5% CO2 for 3 days ...
-
bioRxiv - Cell Biology 2022Quote: ... and stimulated with 25 ng/mL macrophage colony-stimulating factor (MCSF, R&D Systems). After two days ...
-
bioRxiv - Cell Biology 2023Quote: ... 30 ng/ml macrophage colony stimulating factor (M-CSF; R&D Systems, Minnesota, USA) and 100 U/ml penicillin/streptomycin (P/S ...
-
bioRxiv - Neuroscience 2020Quote: ... the antibody was pretreated with or without 5x recombinant human plexin-B3 (His45-Gln1255 (Gln1156Asp) with a C-terminal 6-His tag) (R&D systems) overnight.
-
bioRxiv - Biochemistry 2021Quote: Human anti-SP IgG or ACE-2 Fc was mixed with recombinant SARS-CoV-2 spike RBD His tag (R&D Systems) or recombinant SARS-CoV-2 spike RBD (N501Y)-His tag (Sino Biological ...
-
bioRxiv - Biochemistry 2021Quote: Human CD38 (P28907, a soluble fragment Val43-Ile300 with 6x-His tag at C terminus) was purchased from R&D Systems (USA). It was diluted to final 0.01 mg/ml in 100 mM HEPES/NaOH buffer ...
-
bioRxiv - Immunology 2021Quote: ... or 50 ng/ml macrophage colony- stimulating factor (M-CSF; R&D Systems, Abingdon, UK), respectively ...
-
bioRxiv - Bioengineering 2023Quote: ... + 20 ng/ml recombinant mouse macrophage colony-stimulating factor (M-CSF, R&D systems, 416ML010)) for 6-7 days ...
-
bioRxiv - Cancer Biology 2020Quote: ... His (R&D Systems MAB050-100), COX2 (Abcam ab15191) ...
-
bioRxiv - Cancer Biology 2020Quote: ... His (R&D Systems MAB050-100). Coverslips were incubated with the primary antibody at 4°C overnight and then washed five times for 5 minutes each in PBS following which ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.01 μg ml −1 of granulocyte macrophage colony-stimulating factor (GM-CSF; R&D Systems). After 7 days ...